Data from similar medications shows significant weight regain within 12-18 months of discontinuation
In the as-treated analysis median follow-up was 1 year [0-2] for GLP-1 RA users and 1 year [13] for users of DPP-4 inhibitors
This mechanical distension sends signals to the brain via the vagus nerve, reinforcing satiety
Creating immunoassay tests for peptides would require developing new antibodies for each peptide target
DART-Seq primer beads were stored in TE-TW at 4C
Diabetes Obes Metab 18(2):178185 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial